Science will never be the same again after the latest advances in Artificial Intelligence (IA). Through the good application of technology, Scientists and scholars were recognized by the Nobel Prize for their positive impacts on society. Due to pioneering work in computational protein design, scientist and entrepreneur David Baker won the Nobel Prize for Chemistry 2024.
The awards ceremony was held jointly with Demis Hassabis and John Jumper, Google DeepMind members and AlphaFold developers, system used not experiment. The Nobel Prize for Physics, in turn, was delivered to researchers John Hopfield and Geoffrey Hinton due to their long work with Machine Learning and neural networks.
The research carried out by scientists provided further advances in neural language processes and predictive modeling. This work on neural networks is an achievement for which Hopfield and Hinton are already renowned in the field of physics and technologies.
A quantum leap
The development of synthetic proteins placed Baker, Hassabis and Jumper at the forefront of new possibilities for biotechnology. For that, David Baker explained that, differently from what other scientists do, their designs are created “from scratch”, without modifying proteins existing in nature.
In this process, scientists used AlphaFold. The system has the ability to predict, with greater precision, the structure of proteins based on the sequence of amino acids. This was a challenge that had existed for more than 50 years in the field of biology.
Above all, the approach taken by Google DeepMind members was relevant for bringing valuable neuroscience insights through Deep Learning techniques. This allowed complex problem solving, being very similar to the human brain.
The experience of David Baker and his team
Innovation in protein creation is not Baker's only achievement. The scientist is known for combining science with business. In addition to being a biology professor at the University of Washington,, Baker is director of the Institute of Protein Design, which is seen as a “true startup factory” for uniting the academic world with entrepreneurship.
As a businessman, David Baker founded 21 biotechnology companies. Among them is Charm Therapeutics, specialist in discovering various medicines using AI. Em 2003, his team also released Rosetta software for protein modeling and analysis.
Another renowned company of yours is Icosovax, known for developing vaccines and which this year was acquired by AstraZeneca. Baker also developed universal flu vaccines, Covid e, also, proteins for treating cancer and autoimmune diseases, in addition to other valuable experiments.
AI pioneers
Artificial neural networks are systems that form the basis of modern AI. John Hopfield and Geoffrey Hinton were pioneers in developing this technology in the 1990s. 80. Hopfield created a mathematical model that, It is now known as the “Hopfield Network”.
This would be a structure inspired by the human brain and that simulates the process of storing and retrieving information. Already Hilton, in turn, developed the “Boltzmann Machine”, which would be a neural network that autonomously recognizes patterns.
Both innovations served as a model for technologies currently used in medical diagnostics., virtual assistants and recommendation systems, for example.
